Skip to main content
SpringerLink
Log in

Modulation of mitogenesis by liver fatty acid binding protein

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Liver fatty acid binding protein (L-FABP), a cytoplasmic 14 kDa protein previously termed Z protein, is conventionally considered to be an intracellular carrier of fatty acids in rat hepatocytes. The following evidence now indicates that L-FABP is also a specific mediator of mitogenesis of rat hepatocytes:

  1. a.

    the synergy between the action of L-FABP and unsaturated fatty acids, especially linoleic acid, in the promotion of cell proliferation;

  2. b.

    the specific requirement for L-FABP in induction of mitogenesis by two classes of nongenotoxic hepatocarcinogenic peroxisome proliferators (amphipathic carboxylates and tetrazole-substituted acetophenones);

  3. c.

    the direct correlation between the binding avidities of different prostaglandins for L-FABP and their relative growth inhibitory activities toward cultured rat hepatocytes;

  4. d.

    the temporal coincidences between the covalent binding to L-FABP by chemically reactive metabolites of the genotoxic carcinogens, 2-acetylaminofluorene and aminoazo dyes, and their growth inhibitions of hepatocytes during liver carcinogenesis in rats;

  5. e and f.

    the marked elevations of L-FABP in rat liver during mitosis in normal and regenerating hepatocytes, and during the entire cell cycle in the hyperplastic and malignant hepatocytes that are produced by the genotoxic carcinogens, 2-acetylaminofluorene and aminoazo dyes.

These actions of L-FABP are consistent with those of a protein involved in regulation of hepatocyte multiplication.

Discovery that L-FABP, the target protein of the two types of genotoxic carcinogens, is required for the mitogenesis induced by two classes of nongenotoxic carcinogens points to a common process by which both groups of carcinogens promote hepatocyte multiplication. The implication is that during tumor promotion of liver carcinogenesis, these genotoxic and nongenotoxic carcinogens modify the normal process by which LFABP, functioning as a specific receptor of unsaturated fatty acids or their metabolites, promotes the multiplication of hepatocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levi AJ, Gatmaitan Z, Arias IM: Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest 48: 2156–2167, 1969

    Google Scholar 

  2. Ockner RK, Manning JA, Poppenhaussen RB, Ho WKL: A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 177: 56–58, 1972

    Google Scholar 

  3. Mishkin S, Stein L, Gatmaitan Z, Arias IM: The binding of fatty acids to cytoplasmic proteins: Binding to Z protein in liver and other tissues of the rat. Biochem Biophys Res Commun 47: 997–1003, 1972

    Google Scholar 

  4. Glatz JFC, Baerwaldt CC, Veerkamp JH, Kempen HJM: Diurnal variation of cytosolic fatty acid-binding protein content and of palmitate oxidation in rat liver and heart. J Biol Chem 259: 4295–4300, 1984

    Google Scholar 

  5. Paulussen RJA, Jansen GPM, Veerkamp JH: Fatty acidbinding capacity of cytosolic proteins of various rat tissues: Effect of postnatal development, starvation, sex, clofibrate feeding and light cycle. Biochim Biophys Acta 877: 342–349, 1986

    Google Scholar 

  6. Wilkinson TCI, Wilton DC: Studies on fatty acid-binding proteins. The binding properties of rat liver fatty acid-binding proteins. Biochem J 247: 485–488, 1987

    Google Scholar 

  7. Glatz JFC, Veerkamp JH: Intracellular fatty acid-binding proteins. Int J Biochem 17: 13–22, 1985

    Google Scholar 

  8. Sweetser DA, Heuckeroth RO, Gordon JI: The metabolic significance of mammalian fatty acid-binding proteins. Abundant proteins in search of a function. Annu Rev Nutr 7: 337–359, 1987

    Google Scholar 

  9. Bernier I, Jolles P: A survey on cytosolic nonenzymic proteins involved in the metabolism of lipophilic compounds. From organic anion binders to new protein families. Biochimie 69: 1127–1152, 1987

    Google Scholar 

  10. Bass NM: The cellular fatty acid binding proteins: Aspects of structure, regulation and function. Int Rev Cytol 111: 143–183, 1988

    Google Scholar 

  11. Bass NM; Cellular binding proteins for fatty acids and retinoids: similar or specialized functions? Mol Cellular Biochem 123: 191–202, 1993

    Google Scholar 

  12. Kaikaus RM, Bass NM, Ockner RK: Functions of fatty acid binding proteins. Experientia 46: 617–630, 1990

    Google Scholar 

  13. Kaikaus RM, Chan WK, Ortiz de Montellano PR, Bass NM: Mechanisms of regulation of liver fatty acid-binding protein. Mol Cellular Biochem 123: 93–100, 1993

    Google Scholar 

  14. Paulussen RJA, Veerkamp JH: Intracellular fatty-acid-binding proteins. Characteristics and function. In: Hilderson HJ (ed) Intracellular Transfer of Lipid MOlecules. Plenum Publ Corp, New York, 1990, pp 175–226

    Google Scholar 

  15. Ockner RK, Kaikaus RM, Bass NM: Fatty acid binding proteins: Recent concepts of regulation and function. Progr Clin Biol Res 375: 189–204, 1992

    Google Scholar 

  16. Bass NM: Function and regulation of hepatic and intestinal fatty acid-binding proteins. Chem Phys Lipids 38: 95–114, 1985

    Google Scholar 

  17. Glatz JFC, Paulussen RJA, Veerkamp JH: Fatty acid-binding proteins from heart. Chem Phys Lipids 38: 115–129, 1985

    Google Scholar 

  18. Veerkmap JH, Paulussen RJA: Fatty acid transport in muscle: The role of fatty acid-binding proteins. Biochem Soc Trans 15: 331–336, 1987

    Google Scholar 

  19. Ames BN, Gold LS: Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249: 970–971, 1990

    Google Scholar 

  20. Cohen SM, Ellwein LB: Cell proliferation in carcinogenesis. Science 249: 1007–1011, 1990

    Google Scholar 

  21. Butterworth BE, Slaga T, eds: Chemically induced cell proliferation: Implications for Risk Assessment. Wiley/Liss,New York, 1991

    Google Scholar 

  22. Ketterer B, Tipping E, Hackney JF, Beale D: A low molecular weight protein from rat liver that resembles ligandin in its binding properties. Biochem J 155: 511–521, 1976

    Google Scholar 

  23. Blackburn GR, Andrews JP, Rao KVK, Sorof S: An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen. Cancer Res 40: 4688–4693, 1980

    Google Scholar 

  24. Blackburn GR, Andrews JP, Custer RP, Sorof S: Early events during liver carcinogenesis involving two carcinogen:protein complexes. Cancer Res 41: 4039–4049, 1981

    Google Scholar 

  25. Blackburn GR, Schnabel SJ, Danley JM, Hogue-Angeletti RA, Sorof S: Principal polypeptide target of carcinogen at the beginning of liver carcinogenesis by three carcinogens. Cancer Res 42: 4664–4672, 1982

    Google Scholar 

  26. Bassuk JA, Tsichlis PN, Sorof S: Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Proc Natl Acad Sci USA 84: 7547–7551, 1987

    Google Scholar 

  27. Vinores SA, Churey JJ, Haller JM, Schnabel SJ, Custer RP, Sorof S: Normal liver chromatin contains a firmly bound and larger protein related to the principal cytosolic target polypeptide of a hepatic carcinogen. Proc Natl Acad Sci USA 81: 2092–2096, 1984

    Google Scholar 

  28. Brandes R, Kaikaus RM, Lysenko N, Ockner RK, Bass NM: Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisome β-oxidation. Biochim Biophys Acta 1034: 53–61, 1990

    Google Scholar 

  29. Kanda T, Ono T, Matsubaro Y, Muto T: Possible role of fatty acid-binding protein in the intestines as carriers of phenol and phthalate derivatives. Biochem Biophys Res Commun 168: 1053–1058, 1990

    Google Scholar 

  30. Cannon JR, Eacho PI: Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver. Biochem J 280: 387–391, 1991

    Google Scholar 

  31. Khan S, Sorof S: Liver fatty acid-binding protein: Specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci USA 91: 848–852, 1994

    Google Scholar 

  32. Keler T, Khan S, Sorof S: Liver fatty acid binding protein and mitogenesis in transfected hepatoma cells. In: Honn KV, Marnett LJ, Nigam (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Kluwer Academic Publ, Boston, in press

  33. Raza H, Pongubala JR,Sorof S: Specific high affinity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem Biophys Res Commun 161: 448–455, 1989

    Google Scholar 

  34. Dutta-Roy AK, Gopalswamy N, Trulzsch DV: Prostaglandin E1, binds to Z protein of rat liver. Eur J Biochem 162: 615–619, 1987

    Google Scholar 

  35. Khan SH, Sorof S: Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc Natl Acad Sci USA 87: 9401–9405, 1990

    Google Scholar 

  36. Bonsal MP, Cook RG, Danielson KG, Medina D: A 14-kilodalton selenium-binding protein in mouse liver is fatty acid binding protein. J Biol Chem 264: 13780–13784, 1989

    Google Scholar 

  37. Vancura A, Carroll MA, Haldar D: A lysophosphatidic acid-binding cytosolic protein stimulates mitochondrial glycerophosphate acyltransferase. Biochem Biophys Res Commun 175: 339–343, 1991

    Google Scholar 

  38. Haldar D, Vancura A: Regulation of mitochondrial and microsomal phospholipid synthesis by liver fatty acid-binding protein. J Biol Chem 267: 14353–14359, 1992

    Google Scholar 

  39. Moolenaar WH: Mitogenic action of lysophosphatidic acid. Adv Cancer 57: 87–102, 1991

    Google Scholar 

  40. Vincent SH, Bass NM, Snider JM, Muller-Eberhard U: Are the rat liver cytosolic fatty acid (L-FABP) and hemebinding (HBP) proteins identical? Biochem Arch 3: 443–451, 1987

    Google Scholar 

  41. Liem HH, Grasso JA, Vincent SH, Muller-Eberhard U: Protein-mediated efflux of heme from isolated rat liver mitochondria. Biochem Biophys Res Commun 167: 528–534, 1990

    Google Scholar 

  42. Fukai F, Kase T, Shidotani T, Nagai T, Katayama T: A novel role of fatty acid-binding protein as a vehicle of retinoids. Biochem Biophys Res Commun 147: 889–903, 1987

    Google Scholar 

  43. Burrier RE, Brecher P: Binding of lysophosphatidylcholine to the rat liver fatty acid binding protein. Biochim Biophys Acta 879: 229–239, 1986

    Google Scholar 

  44. Schroeder F, Jefferson JR, Powell D, Incerpi S, Woodford JK, Colles SM, Myers-Payne S, Emge T, Hubbell T, Moncecchi D, Prows DR, Heyliger CE: Expression of rat LFABP in mouse fibroblasts: role in fat absorption. Mol Cell Biochem 123: 78–83, 1993

    Google Scholar 

  45. Lowe JB, Boguski MS, Sweetser DA, Eishourbagy NA, Taylor JM, Gordon JI: Human liver fatty acid binding proteins. Isolation of a full-length cDNA and comparative sequence analyses of orthologous and paralogous proteins. J Biol Chem 260: 3413–3417, 1985

    Google Scholar 

  46. Sweetser DA, Lowe JB, Gordon JI: The nucleotide sequence of the rat liver fatty acid-binding protein gene. Evidence that exon 1 encodes an oligopeptide domain shared by a family of proteins which bind hydrophobic ligands. J Biol Chem 261: 5553–5561, 1986

    Google Scholar 

  47. Sacchettini JC, Gordon JI: Rat intestinal fatty acid binding protein. A model system for analyzing the forces that can bind fatty acids to proteins. J Biol Chem 268: 18399–18402, 1993

    Google Scholar 

  48. Keler T, Barker CS, Sorof S: Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen. Proc Natl Acad Sci USA 89: 4830–4834, 1992

    Google Scholar 

  49. Keler T, Sorof S: Growth promotion of transfected hepatoma cells by liver fatty acid binding protein. J Cellular Physiol 157: 33–40, 1993

    Google Scholar 

  50. Chytil F, Ong DE: Intracellular vitamin A-binding proteins. Annu Rev Nutr 7: 321–335, 1987

    Google Scholar 

  51. Chytil F, Riaz-ul-Haw: Vitamin A mediated gene expression. Crit Revs Eukaryotic Gene Expression 1: 67–73, 1990

    Google Scholar 

  52. Bass NM: Cellular binding proteins for fatty acids and retinoids: similar or specialized functions? Mol Cellular Biochem 123: 191–202, 1993

    Google Scholar 

  53. Böhmer F-D, Kraft R, Otto A, Wernstedt C, Hellman U, Kurtz A, Müller T, Rohde K, Etzold G, Lehmann W, Langen P, Heldin C-H, Grösse R: Identification of a polypeptide growth inhibitor from bovine mammary gland. J Biol Chem 262: 15137–15143, 1987

    Google Scholar 

  54. Grösse R, Langen P: Mammary-derived growth inhibitor. In: Peptide Growth Factor and Receptors: Handbook of Experimental Pharmacol 95: 249–265, 1990

  55. Walz DA, Wider MD, Snow JW, Das C, Desiderio DM: The complete amino acid sequence of porcine gastrophin, an ileal protein which stimulates gastric acid and pepsinogen secretion. J Biol Chem 263: 14189–14195, 1988

    Google Scholar 

  56. Hsu Y-M, Wang JL: Growth control in cultured 3T3 fibroblasts. V. Purification of an Mr 13,000 polypeptide responsible for growth inhibitory activity. J Cell Biol 102: 362–369, 1986

    Google Scholar 

  57. Böhmer F-D, Sun Q, Pepperle M, Müller T, Eriksson D, Wang JL, Grösse R: Antibodies against mammary derived growth inhibitor (MDGI) react with a fibroblast growth inhibitor and with heart fatty acid binding protein. Biochem Biophys Res Commun 148: 1425–1431, 1987

    Google Scholar 

  58. Willis AL (ed) Handbook of Eicosanoids: Prostaglandins and Related Lipids. Vol. 1, Parts A, B. CRC Press, Boca Raton, FL, 1987

    Google Scholar 

  59. Mead JF, Willis AL: The essential fatty acids: Their derivation and role. In: Willis AL (ed) Handbook of Eicosanoids: Prostaglandins and Related Lipids. Vol. 1, Part A. CRC Press, Boca Raton, FL, 1987, pp 85–98

    Google Scholar 

  60. Vallette G, Vanet A, Sumida C, Nunez E: Modulatory effects of unsaturated fatty acids on the binding of glucocorticoids to rat liver glucocorticoid receptors. Endocrinol 129: 1363–1369, 1991

    Google Scholar 

  61. Sumida C, Vallette G, Nunez A: Interaction of unsaturated fatty acids with rat liver glucocorticoid receptors: studies to localize the site of interaction. Acta Endocrinologica 129: 348–355, 1993

    Google Scholar 

  62. Kato J: Arachidonic acid as a possible modulator of estrogen, progestin, androgen, and glucocorticoid receptors in the central and peripheral tissues. J Steroid Biochem 34: 219–227, 1989

    Google Scholar 

  63. Sando JJ, Maurer MC, Bolen EJ, Grisham CM: Role of cofactors in protein kinase C activation. Cellular Signalling 4: 595–609, 1992

    Google Scholar 

  64. Welsch CW: Enhancement of mammary tumorigenesis by dietary fat: Review of potential mechanisms. Am J Clin Nutr 45: 192–202, 1987

    Google Scholar 

  65. Sauer LA, Dauchy RT: Identification of linoleic and arachidonic acids as the factors in hyperlipidemic blood that increase [3H]thymidine incorporation into hepatoma 7288CTC perfusedin situ. Cancer Res 48: 3106–3111, 1988

    Google Scholar 

  66. Wicha MS, Liotta LA, Kidwell WR: Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells. Cancer Res 39: 426–435, 1979

    Google Scholar 

  67. Balakrishnan A, Cramer S, Bandyopadhyay GK, Imagawa W, Yang J, Elias J, Beattie CW, DasGupta TK, Nandi S: Differential proliferative response to linoleate in cultures of epithelial cells from normal human breast and fibroadenomas. Cancer Res 49: 857–862, 1989

    Google Scholar 

  68. Rose DP, Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res 50: 7139–7144, 1990

    Google Scholar 

  69. Or R, Kovar J, Domenico J, Gelfand EW: Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells. Clinical Immunol and Immunopathol 62: 314–320, 1992

    Google Scholar 

  70. Smith DL, Willis AL, Mahmud I: Eicosanoid effects on cell proliferationin vitro: Relevance to atherosclerosis. Prostaglandins, Leukotrienes Med 16: 1–10, 1984

    Google Scholar 

  71. ChangC-C, Duhamel L, Ford-Hutchinson A: Leukotriene B4 and 12-hydroxyeicosatetraenoic acid stimulate epidermal proliferationin vivo in the guinea pig. J Invest Dermatol 85: 333–334, 1985

    Google Scholar 

  72. Bull AW, Nigro ND, Marnett LJ: Structural requirements for stimulation of colonic cell proliferation by oxidized fatty acids. Cancer Res 48: 1771–1776, 1988

    Google Scholar 

  73. Earles SM, Bronstein JC, Winner DL, Bull AW: Metabolism of oxidized linoleic acid: characterization of 13-hy-droxyoctadecadienoic acid dehydrogenase activity from rat colonic tissue. Biochim Biophys Acta 1081: 174–180, 1991

    Google Scholar 

  74. Glasgow WC, Eling TE: Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Mol Pharmacol 38: 503–510, 1990

    Google Scholar 

  75. Dodge W, Thomas M: The effect of 5-hydroxyeicosatetraenoic acid on the proliferation of granulocyte progenitors and embryonic fibroblasts of the chick. Biochem Biophys Res Commun 131: 731–735, 1985

    Google Scholar 

  76. Werner EJ, Dubrowy R, Walenga RW, Stuart MJ: Inhibition of human malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid. Cancer Res 45: 561–563, 1985

    Google Scholar 

  77. Fine RL, Ahn C, Jett M: 5-S-Hydroxyeicosatetraenoic acid (5-S-HETE) modulates PDGF induced DNA synthesis. Proc Am Assoc Cancer Res 33: 82, 1992

    Google Scholar 

  78. Keler T, Barker C, Sorof S: Linoleic acid specifically stimulates the growth of hepatoma cell lines transfected with the target protein of a liver carcinogen. In: Nigam S, Honn KV, Marnett LJ, Walden TL Jr (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Kluwer, Boston, 1993, pp 435–438

    Google Scholar 

  79. Reddy JK, Lalwani ND: Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 12: 1–87, 1983

    Google Scholar 

  80. Hawkins JM, Jones WE, Bonner FW, Gibson GG: The effects of peroxisome proliferators on microsomal, peroxisomal and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441–515, 1987

    Google Scholar 

  81. Lock EA, Mitchell AM, Elcombe CR: Biochemical mechanisms of induction of peroxisome proliferation. Annu Rev Pharmacol Toxicol 29: 145–163, 1989

    Google Scholar 

  82. Bendele AM, Hoover DM, Van Lier RBL, Foxworthy PS, Eacho PI: Effects of chronic treatment with the leukotriene D4-antagonist compound LY171883 on B6C3F1 mice. Fundam Appl Pharmacol 15: 676–682, 1990

    Google Scholar 

  83. Gibson G, Lake B, eds: Peroxisomes: Biology and Importance in Toxicology and Medicine, Taylor & Francis, London, 1993

    Google Scholar 

  84. Eacho PI, Foxworthy PS, Herron DK: Tetrazole-substituted acetophenone peroxisome proliferators: structure-activity relationships and effects on hepatic metabolism. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 343–372

    Google Scholar 

  85. Rao MS, Reddy JK: Biological aspects of peroxisome proliferator-induced liver tumors in the rat. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 513–524

    Google Scholar 

  86. Grasl-Kraupp B, Huber W, Schulte-Hermann R; Are peroxisome proliferators tumor promoters in rat liver? In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 667–693

    Google Scholar 

  87. Popp JA, Cattley RC: Peroxisome proliferators as initiators and promoters of rodent hepatocarcinogenesis. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 653–665

    Google Scholar 

  88. Cattley RC, Marsman DS, Popp JA: Failure of the peroxisome proliferator Wy-14,643 to initiate growth-selectable foci in rat liver. Toxicology 56: 1–7, 1989

    Google Scholar 

  89. Glauert HP, Clark TD: Lack of initiating activity of the peroxisome proliferator ciprofibrate in two stage hepatocarcinogenesis. Cancer Lett 44: 95–100, 1989

    Google Scholar 

  90. Cattley RC, Popp JA: Difference between the promoting activities of the peroxisome proliferators Wy-14,643 and phenobarbital in rat liver. Cancer Res 49: 3246–3251, 1989

    Google Scholar 

  91. Kraup-Grasl B, Huber W, Putz B, Gerbracht V, Schulte-Hermann R: Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res 30: 3701–3708, 1990

    Google Scholar 

  92. Mitchell AM, Lhuguenot J-C, Bridges JW, Elcombe CR: Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl)phthalate. Toxicol Appl Pharmacol 80: 23–32, 1985

    Google Scholar 

  93. Stott WT, Hawkins NC: Risk assessment of chemicals inducing peroxisome proliferation. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 695–721

    Google Scholar 

  94. Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645–650, 1990

    Google Scholar 

  95. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S: The mouse peroxisome proliferator-activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11: 433–439, 1992

    Google Scholar 

  96. Green S: Peroxisome proliferators: A model for receptormediated carcinogenesis. Cancer Surv 14: 221–232, 1992

    Google Scholar 

  97. Green S, Issemann I, Tugwood JD: The molecular mechanism of peroxisome proliferator action. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 99–118

    Google Scholar 

  98. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889–895, 1988

    Google Scholar 

  99. Göttlicher M, Widmark E, Li Q, Gustafson JA: Fatty acids activate chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89: 4653–4657, 1992

    Google Scholar 

  100. Kaikus RM, Chan WK, Lysenko N, Ray R, Ortiz de Montellano PR, Bass NM: Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisomal proliferators. J Biol Chem 268: 9503–9603, 1993

    Google Scholar 

  101. Bass NM, Sadovsky Y, Appell R, Kushner PJ: Dicarboxylic fatty acids activate the peroxisome-proliferator-activated receptor (PPAR) in rat HTC hepatoma cells. Hepatology 18: 125A, 1993

    Google Scholar 

  102. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans R: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771–774, 1992

    Google Scholar 

  103. Bardot O, Alridge TC, Latruffe N, Green S: PPAR-RXR Heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 192: 37–45, 1993

    Google Scholar 

  104. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome-proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160–2164, 1993

    Google Scholar 

  105. Issemann I, Prince R, Tugwood J, Green S: A role for fatty acids and liver fatty adic binding protein in peroxisome proliferation? Biochem Soc 20: 824–827, 1992

    Google Scholar 

  106. Sharma R, Lake BG, Foster J, Gibson GG: Microsomal cytochrome P452 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver. Biochem Pharmacol 37: 1193–1201, 1988

    Google Scholar 

  107. Eacho PI, Foxworthy PS: Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibrate CoA. Biochem Biophys Res Commun 157: 1148–1153, 1988

    Google Scholar 

  108. Foxworthy PS, Eacho PI: Inhibition of hepatic fatty acid oxidation at carnitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl)hexy-loxy]acetophenone. Biochem J 252: 409–414, 1988

    Google Scholar 

  109. Bronfman M: Possible role of Co ASH esters on xenbioticinduced peroxisomal proliferation and non-genotoxic carcinogenesis. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor & Francis, London, 1993, pp 217–245

    Google Scholar 

  110. Ortiz de Montellano PR, Chan WK, Tuck SF, Kaikaus RM, Bass NM, Peterson JA: Mechanism-based probes of the topology and function of fatty acid hydroxylases. FASEB J 6: 695–699, 1992

    Google Scholar 

  111. Kaikaus RM, Sui Z, Lysenko N, Wu NY, Ortiz de Montellano PR, Ockner RK, Bass NM: Regulation of pathways of extramitochondrial fatty acid oxidation and liver fatty acid-binding protein by long-chain monocarboxylic fatty acids in hepatocytes. Effect of inhibition of carnitine transferase I. J Biol Chem 268: 26866–26871, 1993

    Google Scholar 

  112. Fukushima M: Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins, Leukotrienes and Essential Fatty Acids 47: 1–12, 1992

    Google Scholar 

  113. Hitomi M, Odani S, Ono T: Glutathione-protein mixed disulfide decreases the affinity of rat liver fatty acid-binidng protein for unsaturated fatty acids. Eur J Biochem 187: 713–719, 1990

    Google Scholar 

  114. Gordon JI, Alpers DH, Ockner RK, Strauss AW: The nucleotide sequence of rat liver fatty acid binding protein mRNA. J Biol Chem 258: 3356–3363, 1983

    Google Scholar 

  115. Farber E, Cameron R: The sequential analysis of cancer development. Adv Cancer Res 31: 125–226, 1980

    Google Scholar 

  116. Erikson LC, Anderson GN: Membrane biochemistry and chemical hepatocarcinogenesis. Crit Rev Biochem Mol Biol 27: 1–55, 1992

    Google Scholar 

  117. Sorof S, Young EM, McBride RA, Coffey CB: On protein targets of chemical carcinogens: Dissimilar molecular sizes of the principal protein conjugates. Cancer Res 30: 2029–2034, 1970

    Google Scholar 

  118. Ip C: The chemopreventive role of selenium in carcinogenesis. J Am Coll Toxicol 5: 7–20, 1986

    Google Scholar 

  119. Willett WC, Stampfer MJ: Selenium and human cancer: Epidemiological aspects and implications for clinical trials. J Am Coll Toxicol 5: 29–36, 1986

    Google Scholar 

  120. Custer RP, Sorof S: Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Proc Natl Acad Sci USA 81: 6738–6742, 1984

    Google Scholar 

  121. Custer RP, Sorof S: Mitosis in hepatocytes is generally associated with elevated high levels of the target polypeptide of a liver carcinogen. Differentiation 30: 176–181, 1985

    Google Scholar 

  122. Sweetser DA, Birkenmeyer EH, Hoppe PC, McKeel DW, Gordon JI: Mechanisms underlying generation of gradients in gene expression with the intestine: An analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev 2: 1318–1332, 1988

    Google Scholar 

  123. Sorof S, Custer RP: Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Cancer Res 47: 210–220, 1987

    Google Scholar 

  124. Lalwani ND, Fahl WE, Reddy JK: Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochem Biophys Res Commun 116: 388–393, 1983

    Google Scholar 

  125. Lalwani ND, Alvarez K, Reddy MK, Reddy MN, Parikh I, Reddy JK: Peroxisome proliferator-binding protein: Identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver. Proc Natl Acad Sci USA 84: 5242–5246, 1987

    Google Scholar 

  126. Alvarez K, Carillo A, Yuan PM, Kawano H, Morimoto RI, Reddy JK: Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP70 family. Proc Natl Acad Sci USA 87: 5293–5297, 1990

    Google Scholar 

  127. Gibson GG; Peroxisome proliferators: Paradigms and prospects. Toxicol Letters 68: 193–201, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Cancer Research, Fox Chase Cancer Center, 7701 Burholme Avenue, 19111, Philadelphia, PA, USA

    Sam Sorof

Authors
  1. Sam Sorof
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sorof, S. Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metast Rev 13, 317–336 (1994). https://doi.org/10.1007/BF00666102

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00666102

Key words

Search

Navigation